Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A

L M MulliganL Papi


Multiple endocrine neoplasia type 2A (MEN 2A) is a dominantly inherited cancer syndrome that affects tissues derived from neural ectoderm. It is characterized by medullary thyroid carcinoma (MTC) and phaeochromocytoma. The MEN2A gene has recently been localized by a combination of genetic and physical mapping techniques to a 480-kilobase region in chromosome 10q11.2 (refs 2,3). The DNA segment encompasses the RET proto-oncogene, a receptor tyrosine kinase gene expressed in MTC and phaeochromocytoma and at lower levels in normal human thyroid. This suggested RET as a candidate for the MEN2A gene. We have identified missense mutations of the RET proto-oncogene in 20 of 23 apparently distinct MEN 2A families, but not in 23 normal controls. Further, 19 of these 20 mutations affect the same conserved cysteine residue at the boundary of the RET extracellular and transmembrane domains.


Oct 25, 1991·Nucleic Acids Research·L M MulliganB A Ponder
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N R RodriguesD P Lane
Dec 25, 1990·Nucleic Acids Research·T TahiraM Nagao
Jun 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R G CottonR D Campbell
Jan 1, 1984·Annual Review of Medicine·R N Schimke
Mar 1, 1993·Genes, Chromosomes & Cancer·L M MulliganB A Ponder

❮ Previous
Next ❯


Oct 1, 1996·The Journal of Pathology·G H WilliamsE D Williams
Jul 17, 1998·The Journal of Pathology·D G WangK D Buchanan
Dec 31, 1997·Microscopy Research and Technique·E I WallnerY S Kanwar
Jun 1, 2000·Cancer Control : Journal of the Moffitt Cancer Center·G W Randolph, D Maniar
Oct 7, 1998·International Journal of Cancer. Journal International Du Cancer·E van der HarstP Komminoth
Aug 14, 1999·International Journal of Cancer. Journal International Du Cancer·I BiècheR Lidereau
Nov 22, 1997·Journal of Neurobiology·B W BisgroveD J Grunwald
Jun 1, 1996·Genes, Chromosomes & Cancer·W H RaskindM Matsushita
Nov 7, 2000·Genes, Chromosomes & Cancer·N PaunuH Haapasalo
May 1, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P EderyS Lyonnet
Jan 1, 1995·Genes, Chromosomes & Cancer·A IidaT Imai
Mar 1, 1995·Genes, Chromosomes & Cancer·C EngM J Lorenzo
Sep 1, 1994·The Clinical Investigator·H P Neumann
Jun 1, 1995·Mammalian Genome : Official Journal of the International Mammalian Genome Society·F CanzianI Ceccherini
Jan 1, 1997·Pediatric Surgery International·G Martucciello
Jan 1, 1997·Pediatric Surgery International·T Kusafuka, P Puri
Jan 1, 1996·Journal of Cancer Research and Clinical Oncology·A G Knudson
Jan 1, 1995·Endocrine Pathology·Paul KomminothPhilipp U. Heitz
Apr 1, 1996·Endocrine Pathology·Iris WundrackNikolaus Blin
Apr 29, 1998·Molecular Neurobiology·M Israël, Y Dunant
Dec 30, 1998·Irish Journal of Medical Science·D A O'KeeffeN J O'Higgins
Jan 19, 2006·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·O GimmH Dralle
Dec 6, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·A Frilling, F Weber
Feb 7, 2007·Der Pathologe·G MartuccielloU Magrini
Mar 28, 2008·Pediatric Surgery International·S W Moore, M G Zaahl
Jun 13, 2009·Pediatric Surgery International·Paul K H Tam, Mercè Garcia-Barceló
Mar 5, 2013·Langenbeck's Archives of Surgery·Henning DralleUNKNOWN German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hem
May 11, 2005·Familial Cancer·Mariola Peczkowska, Andrzej Januszewicz
Oct 13, 2006·Pituitary·Yoshiki MurakumoMasahide Takahashi
Aug 29, 2003·Current Treatment Options in Oncology·Jeffrey F Moley
Jun 22, 2005·Current Treatment Options in Oncology·Amber Traugott, Jeffrey F Moley
Aug 4, 2006·Current Hypertension Reports·Maciej TomaszewskiAnna F Dominiczak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.